Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Milgram

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of the American Thoracic Society|June 26, 2014
Asthma medications should be available for over-the-counter use: conLaura J H Milgram
The Journal of Membrane Biology|June 6, 1977
Membrane permeability equations and their solutions for red cellsJ H Milgram, A K Solomon
Pediatric Pulmonology|January 22, 2002
Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosisRichard C Ahrens, Thomas A Standaert, Janice Launspach, et al.
Pediatric Pulmonology|April 20, 2004
Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trialsThomas A Standaert, Louis Boitano, Julia Emerson, et al.
Pediatric Pulmonology|January 22, 2002
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosisNael A McCarty, Thomas A Standaert, Mary Teresi, et al.
Human Gene Therapy|February 3, 2005
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitutionMichael W Konstan, Pamela B Davis, Jeffrey S Wagener, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of the American Thoracic Society|June 26, 2014
Asthma medications should be available for over-the-counter use: conLaura J H Milgram
The Journal of Membrane Biology|June 6, 1977
Membrane permeability equations and their solutions for red cellsJ H Milgram, A K Solomon
Pediatric Pulmonology|January 22, 2002
Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosisRichard C Ahrens, Thomas A Standaert, Janice Launspach, et al.
Pediatric Pulmonology|April 20, 2004
Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trialsThomas A Standaert, Louis Boitano, Julia Emerson, et al.
Pediatric Pulmonology|January 22, 2002
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosisNael A McCarty, Thomas A Standaert, Mary Teresi, et al.
Human Gene Therapy|February 3, 2005
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitutionMichael W Konstan, Pamela B Davis, Jeffrey S Wagener, et al.
Pageof 1